Publication | Closed Access

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

Adjuvant Bevacizumab-containing TherapyBreast OncologyMedicinePrimary ResultsImmunologyBreast CancerTriple-negative Breast CancerCancer TreatmentOncologyRadiation Oncology